These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 3880404)
1. Tardive dyskinesia in Tourette syndrome. Golden GS Pediatr Neurol; 1985; 1(3):192-4. PubMed ID: 3880404 [TBL] [Abstract][Full Text] [Related]
2. Haloperidol-induced tardive dyskinesia in a child with Gilles de la Tourette's disease. Mizrahi EM; Holtzman D; Tharp B Arch Neurol; 1980 Dec; 37(12):780. PubMed ID: 6934716 [TBL] [Abstract][Full Text] [Related]
3. Tardive dyskinesia and chronic neuroleptic treatment of Tourette patients. Shapiro E; Shapiro AK Adv Neurol; 1982; 35():413. PubMed ID: 6959518 [No Abstract] [Full Text] [Related]
4. Gilles de la Tourette's syndrome, tardive dyskinesia, and psychosis in an adolescent. Caine ED; Margolin DI; Brown GL; Ebert MH Am J Psychiatry; 1978 Feb; 135(2):241-3. PubMed ID: 272123 [No Abstract] [Full Text] [Related]
5. Tardive dyskinesia following haloperidol treatment in Tourette's syndrome. Riddle MA; Hardin MT; Towbin KE; Leckman JF; Cohen DJ Arch Gen Psychiatry; 1987 Jan; 44(1):98-9. PubMed ID: 3467661 [No Abstract] [Full Text] [Related]
6. Tardive dyskinesia in persons with Gilles de la Tourette's disease. Caine ED; Polinsky RJ Arch Neurol; 1981 Jul; 38(7):471-2. PubMed ID: 6941749 [No Abstract] [Full Text] [Related]
10. Behavioral effects of haloperidol in young Tourette syndrome patients. Bogomolny A; Erenberg G; Rothner AD Adv Neurol; 1982; 35():427-32. PubMed ID: 6959520 [No Abstract] [Full Text] [Related]
11. Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder. Bruun RD Am J Psychiatry; 1988 May; 145(5):621-4. PubMed ID: 2895987 [TBL] [Abstract][Full Text] [Related]
13. Treatment approaches in Gilles de la Tourette syndrome. Borison RL; Ang L; Hamilton WJ; Diamond BI; Davis JM Brain Res Bull; 1983 Aug; 11(2):205-8. PubMed ID: 6578865 [TBL] [Abstract][Full Text] [Related]
14. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol. Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983 [TBL] [Abstract][Full Text] [Related]
15. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184 [TBL] [Abstract][Full Text] [Related]
16. Treating Tourette syndrome with haloperidol: predictors of success. Schwabe MJ; Konkol RJ Wis Med J; 1989 Oct; 88(10):23-7. PubMed ID: 2815810 [TBL] [Abstract][Full Text] [Related]
17. Amantadine in Tourette syndrome. Borison RL; Davis JM Curr Psychiatr Ther; 1983; 22():127-30. PubMed ID: 6587960 [No Abstract] [Full Text] [Related]
19. Lithium carbonate in the treatment of movement disorders. A critical review. Yassa R; Ananth J Int Pharmacopsychiatry; 1980; 15(5):301-8. PubMed ID: 6114936 [TBL] [Abstract][Full Text] [Related]
20. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol. Beasley CM; Dellva MA; Tamura RN; Morgenstern H; Glazer WM; Ferguson K; Tollefson GD Br J Psychiatry; 1999 Jan; 174():23-30. PubMed ID: 10211147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]